Tissue Engineered Bile Ducts for Disease Modeling and Therapy

Publication date

2021

Authors

Wang, ZhenguoISNI 0000000512658747
Faria, Joao
Penning, L.C.ISNI 000000039077188X
Masereeuw, RosalindeORCID 0000-0002-1560-1074ISNI 0000000369326917
Spee, BartORCID 0000-0002-8114-0560ISNI 0000000395759855

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Recent biotechnical advances in the in vitro culture of cholangiocytes and generation of bioengineered biliary tissue have a high potential for creating biliary tissue to be used for disease modeling, drug screening and transplantation. For the past few decades, scientists have searched for a source of cholangiocytes, focused on primary cholangiocytes or cholangiocytes derived from hepatocytes or stem cells. At the same time, the development of scaffolds for biliary tissue engineering for transplantation and modeling of cholangiopathies have been explored. Here, we provide an overview on the current understanding of cholangiocytes sources, the effect of signaling molecules and transcription factors on cell differentiation, along with the effects of extracellular matrix molecules and scaffolds on bioengineered biliary tissues, and their application in disease modeling and drug screening.

Keywords

Citation

Wang, Z, Faria, J, Penning, L, Masereeuw, R & Spee, B 2021, 'Tissue Engineered Bile Ducts for Disease Modeling and Therapy', Tissue engineering. Part C, Methods, vol. 27, no. 2, pp. 59-76. https://doi.org/10.1089/ten.TEC.2020.0283